
Sign up to save your podcasts
Or
In this week’s View, Dr. Eagle explores the role of inflammation as a predictor of coronary risk. He then discusses the safety and efficacy of renal denervation in patients taking antihypertensive medications. Finally, Dr. Eagle examines amiodarone and pulmonary toxicity in atrial fibrillation.
Subscribe to Eagle’s Eye View
4.7
128128 ratings
In this week’s View, Dr. Eagle explores the role of inflammation as a predictor of coronary risk. He then discusses the safety and efficacy of renal denervation in patients taking antihypertensive medications. Finally, Dr. Eagle examines amiodarone and pulmonary toxicity in atrial fibrillation.
Subscribe to Eagle’s Eye View
139 Listeners
322 Listeners
170 Listeners
872 Listeners
502 Listeners
31 Listeners
282 Listeners
3,333 Listeners
1,111 Listeners
60 Listeners
38 Listeners
195 Listeners
350 Listeners
424 Listeners
38 Listeners